The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study. Issue 2 (December 2015) - Regan, Courtney; Nishimura, Michael; Le Poole, I; Godellas, Constantine; Stiff, Patrick; Garrett-Mayer, Elizabeth; Li, Mingli; Shirai, Keisuke; Eby, Jonathan; Embree, Heather; Dropulic, Boro; Clark, Ann; et al.